Organogenesis Inc. has exclusively licensed its Testskin andrelated in vitro testing products to Toyobo Co. Ltd. formanufacture and sale in Japan. The Canton, Mass., company willreceive royalties on product sales.
Organogenesis discontinued the manufacture and sales ofTestskin, a full-thickness living skin equivalent, last January inorder to focus on the medical applications of its technology. Thecompany's GraftSkin is in clinicals as a replacement for skinlost to burns, clean excision wounds and skin ulcers, and as atemporary dressing for burns and skin wounds.
(c) 1997 American Health Consultants. All rights reserved.